Serum Levels of Hepcidin in Rheumatoid Arthritis and Its Correlation with Disease Activity and Anemia: A Meta-analysis

References

• Abdel-Khalek MA, El-Barbary AM, Essa SA, Ghobashi AS. 2011. Serum hepcidin: a direct link between anemia of inflammation and coronary artery atherosclerosis in patients with rheumatoid arthritis. J Rheumatol. 38(10):2153–59.
   PubMed Web of Science ®Google Scholar
• Andrews NC. 2004. Anemia of inflammation: the cytokine-hepcidin link. J Clin Invest. 113(9):1251–53.
   PubMed Web of Science ®Google Scholar
• Cronstein BN. 2007. Interleukin-6–a key mediator of systemic and local symptoms in rheumatoid arthritis. Bull NYU Hosp Jt Dis. 65(Suppl 1):S11–5.
   PubMedGoogle Scholar
• Cross M, Smith E, Hoy D, Carmona L, Wolfe F, Vos T, Williams B, Gabriel S, Lassere M, Johns N, et al. 2014. The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 73(7):1316–22.
   PubMed Web of Science ®Google Scholar
• David M, Alessandro L, Jennifer T, Douglas. 2010. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 8(5):336–41.
   PubMed Web of Science ®Google Scholar
• De Domenico I, Ward DM, Langelier C, Vaughn MB, Nemeth E, Sundquist WI, Ganz T, Musci G, Kaplan J. 2007. The molecular mechanism of hepcidin-mediated ferroportin down-regulation. Mol Biol Cell. 18(7):2569–78.
   PubMed Web of Science ®Google Scholar
• De Domenico I, Zhang TY, Koening CL, Branch RW, London N, Lo E, Daynes RA, Kushner JP, Li D, Ward DM, et al. 2010. Hepcidin mediates transcriptional changes that modulate acute cytokine-induced inflammatory responses in mice. J Clin Invest. 120(7):2395–405.
   PubMed Web of Science ®Google Scholar
• Demirag MD, Haznedaroglu S, Sancak B, Konca C, Gulbahar O, Ozturk MA, Goker B. 2009. Circulating hepcidin in the crossroads of anemia and inflammation associated with rheumatoid arthritis. Intern Med. 48(6):421–26.
   PubMed Web of Science ®Google Scholar
• Firestein GS. 2003. Evolving concepts of rheumatoid arthritis. Nature. 423(6937):356–61.
   PubMed Web of Science ®Google Scholar
• Flanagan JM, Truksa J, Peng H, Lee P, Beutler E. 2007. In vivo imaging of hepcidin promoter stimulation by iron and inflammation. Blood Cells Mol Dis. 38(3):253–57.
   PubMed Web of Science ®Google Scholar
• Ganz T. 2003. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood. 102(3):783–88.
   PubMed Web of Science ®Google Scholar
• Ganz T. 2005. Hepcidin–a regulator of intestinal iron absorption and iron recycling by macrophages. Best Pract Res Clin Haematol. 18(2):171–82.
   PubMed Web of Science ®Google Scholar
• Geerts I, Vermeersch P, Joosten E. 2012. Evaluation of the first commercial hepcidin ELISA for the differential diagnosis of anemia of chronic disease and iron deficiency anemia in hospitalized geriatric patients. ISRN Hematol. 2012(567491):1–3.
   Google Scholar
• Goodnough LT, Nemeth E, Ganz T. 2010. Detection, evaluation, and management of iron-restricted erythropoiesis. Blood. 116(23):4754–61.
   PubMed Web of Science ®Google Scholar
• Griffiths WJ. 2007. Review article: the genetic basis of haemochromatosis. Aliment Pharmacol Ther. 26(3):331–42.
   PubMed Web of Science ®Google Scholar
• Han C, Rahman MU, Doyle MK, Bathon JM, Smolen J, Kavanaugh A, Westhovens R, St Clair EW, Baker D, Bala M. 2007. Association of anemia and physical disability among patients with rheumatoid arthritis. J Rheumatol. 34(11):2177–82.
   PubMed Web of Science ®Google Scholar
• Hansen NE. 1983. The anaemia of chronic disorders: a bag of unsolved questions. Scand J Haematol. 31(5): 397–402.
   PubMedGoogle Scholar
• Higgins JP, Thompson SG, Deeks JJ, Altman DG. 2003. Measuring inconsistency in meta-analyses. BMJ. 327(7414):557–60.
   PubMed Web of Science ®Google Scholar
• Hirano T, Matsuda T, Turner M, Miyasaka N, Buchan G, Tang B, Sato K, Shimizu M, Maini R, Feldmann M, et al. 1988. Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur J Immunol. 18(11):1797–801.
   PubMed Web of Science ®Google Scholar
• Jayaranee S, Sthaneshwar P, Sokkalingam S. 2009. Serum prohepcidin concentrations in rheumatoid arthritis. Pathology. 41(2):178–82.
   PubMed Web of Science ®Google Scholar
• Kemna E, Pickkers P, Nemeth E, van der Hoeven H, Swinkels D. 2005. Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. Blood. 106(5):1864–66.
   PubMed Web of Science ®Google Scholar
• Kemna EH, Tjalsma H, Willems HL, Swinkels DW. 2008. Hepcidin: from discovery to differential diagnosis. Haematologica. 93(1):90–97.
   PubMed Web of Science ®Google Scholar
• Kirkwood KL, Zhang L, Thiyagarajan R, Seldeen KL, Troen BR. 2018. Myeloid-derived suppressor cells at the intersection of inflammaging and bone fragility. Immunol Invest. 47(8):844–54.
   PubMed Web of Science ®Google Scholar
• Koca SS, Ateş O, Üstündağ B, ÇELİKER Ü, Özgen M, Işik A. 2008a. Serum prohepcidin level in Behçet’s disease. Turkiye Klinikleri Journal of Medical Sciences. 28(5):601–05.
   Google Scholar
• Koca SS, Isik A, Ustundag B, Metin K, Aksoy K. 2008b. Serum pro-hepcidin levels in rheumatoid arthritis and systemic lupus erythematosus. Inflammation. 31(3):146–53.
   PubMed Web of Science ®Google Scholar
• Krause A, Neitz S, Magert HJ, Schulz A, Forssmann WG, Schulz-Knappe P, Adermann K. 2000. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett. 480(2–3):147–50.
   PubMed Web of Science ®Google Scholar
• Kulaksiz H, Gehrke SG, Janetzko A, Rost D, Bruckner T, Kallinowski B, Stremmel W. 2004. Pro-hepcidin: expression and cell specific localisation in the liver and its regulation in hereditary haemochromatosis, chronic renal insufficiency, and renal anaemia. Gut. 53(5):735–43.
   PubMed Web of Science ®Google Scholar
• Manolov V, Paskaleva-Peycheva V, Velizarova M, Atanasova B, Hadjidekova S, Tzatchev K, Bogov I, Genchev GGrozdanova R. 2014. New tools in diagnosis of anemia in rheumatoid arthritis. International Journal of Development Research. 4(12):2743–45.
   Google Scholar
• Means RT Jr. 2004. Hepcidin and anaemia. Blood Rev. 18(4):219–25.
   PubMed Web of Science ®Google Scholar
• Melsen WG, Bootsma MC, Rovers MM, Bonten MJ. 2014. The effects of clinical and statistical heterogeneity on the predictive values of results from meta-analyses. Clin Microbiol Infect. 20(2):123–29.
   PubMed Web of Science ®Google Scholar
• Moller B, Scherer A, Forger F, Villiger PM, Finckh A. 2014. Anaemia may add information to standardised disease activity assessment to predict radiographic damage in rheumatoid arthritis: a prospective cohort study. Ann Rheum Dis. 73(4):691–96.
   PubMed Web of Science ®Google Scholar
• Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, Ganz T. 2004a. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 113(9):1271–76.
   PubMed Web of Science ®Google Scholar
• Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J. 2004b. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 306(5704):2090–93.
   PubMed Web of Science ®Google Scholar
• Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T. 2003. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood. 101(7):2461–63.
   PubMed Web of Science ®Google Scholar
• Nicolas G, Chauvet C, Viatte L, Danan JL, Bigard X, Devaux I, Beaumont C, Kahn A, Vaulont S. 2002. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest. 110(7):1037–44.
   PubMed Web of Science ®Google Scholar
• Ostgard RD, Glerup H, Jurik AG, Kragstrup TW, Stengaard-Pedersen K, Hetland ML, Horslev-Petersen K, Junker P, Deleuran BW. 2017. Hepcidin plasma levels are not associated with changes in haemoglobin in early rheumatoid arthritis patients. Scand J Rheumatol. 46(6):441–45.
   PubMed Web of Science ®Google Scholar
• Pagani A, Nai A, Corna G, Bosurgi L, Rovere-Querini P, Camaschella C, Silvestri L. 2011. Low hepcidin accounts for the proinflammatory status associated with iron deficiency. Blood. 118(3):736–46.
   PubMed Web of Science ®Google Scholar
• Park CH, Valore EV, Waring AJ, Ganz T. 2001. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem. 276(11):7806–10.
   PubMed Web of Science ®Google Scholar
• Peeters HR, Jongen-Lavrencic M, Raja AN, Ramdin HS, Vreugdenhil G, Breedveld FC, Swaak AJ. 1996. Course and characteristics of anaemia in patients with rheumatoid arthritis of recent onset. Ann Rheum Dis. 55(3):162–68.
   PubMed Web of Science ®Google Scholar
• Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, Loreal O. 2001. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem. 276(11):7811–19.
   PubMed Web of Science ®Google Scholar
• Roetto A, Papanikolaou G, Politou M, Alberti F, Girelli D, Christakis J, Loukopoulos D, Camaschella C. 2003. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet. 33(1):21–22.
   PubMed Web of Science ®Google Scholar
• Sabău A, Văleanu M, Boloşiu HDCrăciun AM. 2013. Evaluation of serum hepcidin variation in patients with rheumatoid arthritis according to anemia profile and its correlation with disease activity. Romanian Review of Laboratory Medicine. 21(1):17–27.
   Web of Science ®Google Scholar
• Sahebari M, Rezaieyazdi Z, Hashemy SI, Khorasani S, Shahgordi S, Alizadeh MK, Ghaeni A, Khodashahi M. 2018. Serum hepcidin level and rheumatoid arthritis disease activity. Eur J Rheumatol. 6(2):76–80.
   PubMed Web of Science ®Google Scholar
• Scholz GA, Leichtle AB, Scherer A, Arndt U, Fiedler M, Aeberli D, Finckh A, Gabay C, Kyburz DVilliger PM. 2019. The links of hepcidin and erythropoietin in the interplay of inflammation and iron deficiency in a large observational study of rheumatoid arthritis. Br J Haematol. 186(1):101–12.
   PubMed Web of Science ®Google Scholar
• Sellam J, Kotti S, Fellahi S, Bastard JP, Meyer M, Liote F, Meyer O, Simon T, Capeau J, Berenbaum F. 2013. Serum hepcidin level is not an independent surrogate biomarker of disease activity or of radiographic progression in rheumatoid arthritis: results from the ESPOIR cohort. Ann Rheum Dis. 72(2):312–14.
   PubMed Web of Science ®Google Scholar
• Stefanova KI, Delcheva GT, Maneva AI, Batalov AZ, Geneva-Popova MG, Karalilova RV, Simitchiev KK. 2016. Pathobiochemical mechanisms relating iron homeostasis to parameters of inflammatory activity and autoimmune disorders in rheumatoid arthritis. Folia Med (Plovdiv). 58(4):257–63.
   PubMedGoogle Scholar
• Stefanova KI, Delcheva GT, Maneva AI, Batalov AZ, Geneva-Popova MG, Karalilova RVSimitchiev KK. 2018. Pathobiochemical mechanisms relating iron homeostasis with parameters of inflammatory activity and autoimmune disorders in rheumatoid arthritis. Folia Med (Plovdiv). 58(4):257–63.
   Google Scholar
• Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. 2000. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. Jama. 283(15):2008–12.
   PubMed Web of Science ®Google Scholar
• Taghadosi M, Samimi Z, Assar S, Salahshoor MR, Jalili C. 2020. Plasma leptin does not reflect the effect of high body mass index on disease activity in rheumatoid arthritis. Immunol Invest. 49(1–2):32–45.
   PubMed Web of Science ®Google Scholar
• Teke HU, Cansu DU, Yildiz P, Temiz G, Bal C. 2017. Clinical significance of serum IL-6, TNF-α, hepcidin, and EPO levels in anaemia of chronic disease and iron deficiency anaemia: the laboratory indicators for anaemia. Biomedical Research. 28:2704–10.
   Google Scholar
• van Steenbergen HW, van Nies JA, van der Helm-van Mil AH. 2013. Anaemia to predict radiographic progression in rheumatoid arthritis. Ann Rheum Dis. 72(7):e16.
   PubMed Web of Science ®Google Scholar
• Vreugdenhil G, Baltus JA, van Eijk HG, Swaak AJ. 1989. Prediction and evaluation of the effect of iron treatment in anaemic RA patients. Clin Rheumatol. 8(3):352–62.
   PubMed Web of Science ®Google Scholar
• Wahle M. 2012. [Anemia in patients with rheumatoid arthritis.]. Zeitschrift Für Rheumatologie. 71(10):864–68.
   PubMed Web of Science ®Google Scholar
• Wan X, Wang W, Liu J, Tong T. 2014. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 14:135.
   PubMed Web of Science ®Google Scholar
• Wrighting DM, Andrews NC. 2006. Interleukin-6 induces hepcidin expression through STAT3. Blood. 108(9):3204–09.
   PubMed Web of Science ®Google Scholar
• Wu XD, Zhang Z, Chen Y, Xie BH, Gan MZ, Huang XQLiu L. 2013. Association of serum bone morphogenetic protein-6 and hepcidin levels with anemia in patients with rheumatoid arthritis. Zhejiang Medical Journal. 35(18):1632–36.
   Google Scholar
• Young A, Koduri G. 2007. Extra-articular manifestations and complications of rheumatoid arthritis. Best Pract Res Clin Rheumatol. 21(5):907–27.
   PubMed Web of Science ®Google Scholar
• Yunt ZX, Solomon JJ. 2015. Lung disease in rheumatoid arthritis. Rheum Dis Clin North Am. 41(2):225–36.
   PubMed Web of Science ®Google Scholar
• Zeng T, Song CY, Shi DGu KF. 2015. Significance of hepcidin in patients with rheumatoid arthritis. Chinese Journal of Difficult and Complicated Cases. 14(1):33–35.
   Google Scholar